Meclofenamic acid

Meclofenamic acid

• Description :

  Meclofenamic acid (Meclofenamate) is a non-steroidal anti-inflammatory agent. Meclofenamic acid is a highly selective FTO (fat mass and obesity-associated) enzyme inhibitor. Meclofenamic acid competes with FTO binding for the m (6) A-containing nucleic acid. Meclofenamic acid is a non-selective gap-junction blocker. Meclofenamic acid inhibits hKv2.1 and hKv1.1, with IC50 values of 56.0 and 155.9 μM, respectively[1][2][3][4].

• Product Name Alternative :

  Meclofenamate

• UNSPSC :

  12352005

• Hazard Statement :

  H301

• Target :

  Endogenous Metabolite; Fat Mass and Obesity-associated Protein (FTO) ; Gap Junction Protein; Potassium Channel

• Type :

  Reference compound

• Related Pathways :

  Cytoskeleton; Membrane Transporter/Ion Channel; Metabolic Enzyme/Protease

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Metabolic Disease; Inflammation/Immunology; Neurological Disease

• Assay Protocol :

  https://www.medchemexpress.com/meclofenamic-acid.html

• Purity :

  99.66

• Solubility :

  DMSO : 100 mg/mL (ultrasonic) |Methanol : 7.14 mg/mL (ultrasonic)

• Smiles :

  O=C(O)C1=CC=CC=C1NC2=C(Cl)C=CC(C)=C2Cl

• Molecular Formula :

  C14H11Cl2NO2

• Molecular Weight :

  296.15

• Precautions :

  H301

• References & Citations :

  [1]Conroy MC, et al. Pharmacology, pharmacokinetics, and therapeutic use of meclofenamate sodium. Clin J Pain. 1991;7 Suppl 1:S44-8.|[2]Eleftheriou CG, et al. Meclofenamic acid improves the signal to noise ratio for visual responses produced by ectopicexpression of human rod opsin. Mol Vis. 2017 Jun 16;23:334-345. eCollection 2017.|[3]Huang Y, et al. Meclofenamic acid selectively inhibits FTO demethylation of m6A over ALKBH5. Nucleic Acids Res. 2015 Jan;43 (1) :373-84.|[4]Lee YT, et al. Inhibition of hKv2.1, a major human neuronal voltage-gated K+ channel, by meclofenamic acid. Eur J Pharmacol. 1999 Aug 13;378 (3) :349-56.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  Launched

• Citation 01 :

  Biomed Opt Express. 2021 Mar 9;12 (4) :1962-1973.|SSRN. 2025 Jan 27.|Biomater Adv. 2023 Nov:154:213634.|Cancer Commun (Lond) . 2025 May;45 (5) :608-631.|PLoS Pathog. 2025 Jan 21;21 (1) :e1012895.|Sensor Actuat B-Chem. 2021, 129983.|Theranostics. 2021 Jul 25;11 (17) :8464-8479.

• CAS Number :

  [644-62-2]